Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Hematology & Oncology
Published in: Journal of Hematology & Oncology 1/2011

Open Access 01-12-2011 | Letter to the Editor

Allogeneic hematopoietic stem cell transplantation for acute leukemia with Gilbert's syndrome

Authors: Guo-Pan Yu, Qian-Li Jiang, Zhi-Ping Fan, Jie Zhao, Qi Wei, Jing Sun, Fan-Yi Meng, Qi-Fa Liu

Published in: Journal of Hematology & Oncology | Issue 1/2011

Login to get access

Abstract

Acute leukemia with coexisting Gilbert's syndrome treated by allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rarely reported. Here we described a case whose transaminase levels were almost normal, although transient hyperbilirubinemia repeatedly happened during chemotherapy.
Appendix
Available only for authorised users
Literature
1.
Bosma PJ: Inherited disorders of bilirubin metabolism. J Hepatol. 2003, 38 (1): 107-117. 10.1016/S0168-8278(02)00359-8.CrossRefPubMed
2.
Ruiz-Arguelles GJ, Ruiz-Delgado GJ, David Gomez-Rangel J, Gomez-Almaguer D: Gilbert's syndrome disclosed during the treatment of hematological malignancies. Hematology. 2005, 10 (1): 59-60. 10.1080/10245330410001727064.CrossRefPubMed
3.
Singer JB, Shou Y, Giles F, Kantarjian HM, Hsu Y, Robeva AS, Rae P, Weitzman A, Meyer JM, Dugan M, Ottmann OG: UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia. Leukemia. 2007, 21: 2311-2315. 10.1038/sj.leu.2404827.CrossRefPubMed
4.
Xu CF, Reck BH, Xue Z, Huang L, Baker KL, Chen M, Chen EP, Ellens HE, Mooser VE, Cardon LR, Spraggs CF, Pandite L: Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. BJC. 2010, 102: 1371-1377. 10.1038/sj.bjc.6605653.PubMedCentralCrossRefPubMed
5.
Ravindranath Y, Brecht I, Feldman J, Severson RK, Nahhas F, Nahar A, Goyette G: High frequency of Gilbert's syndrome in ETV6/RUNX1-positive childhood acute lymphoblastic leukemia (ALL): Implications for etiology. J Clin Oncol. 2010, 28: 15s-(suppl; abstr 9576)
6.
7.
Pidala J, Kim J, Anasetti C, Kharfan-Dabaja MA, Field T, Perkins J, Ayala E, Perez L, Fernandez H: Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity. Bone Marrow Transplant. 2010,
8.
Fabris L, Cadamurob M, Okolicsanyi L: The patient presenting with isolated hyperbilirubinemia. Dig Liver Dis. 2009, 41 (6): 375-381. 10.1016/j.dld.2008.11.006.CrossRefPubMed
9.
Hallal PH, Egea JM, Mas P, Garcia MD, Perez-Cuadrado E, Carballo F: Prueba breve (2 horas) con rifampicina: una herramienta útil en el síndrome de Gilbert. Gastroenterol Hepatol. 2006, 29: 63-65.PubMed
Metadata
Title
Allogeneic hematopoietic stem cell transplantation for acute leukemia with Gilbert's syndrome
Authors
Guo-Pan Yu
Qian-Li Jiang
Zhi-Ping Fan
Jie Zhao
Qi Wei
Jing Sun
Fan-Yi Meng
Qi-Fa Liu
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Hematology & Oncology / Issue 1/2011
Electronic ISSN: 1756-8722
DOI
https://doi.org/10.1186/1756-8722-4-9

Other articles of this Issue 1/2011

Journal of Hematology & Oncology 1/2011 Go to the issue

Letter to the Editor

Significance of differential expression of thymidylate synthase in normal and primary tumor tissues from patients with colorectal cancer

Research

Generation of diffuse large B cell lymphoma-associated antigen-specific Vα6/Vβ13+T cells by TCR gene transfer

Case report

Oral ezatiostat HCl (Telintra®, TLK199) and Idiopathic Chronic Neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following treatment with ezatiostat, a glutathione S-transferase P1-1 (GSTP1-1) inhibitor

Research

Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4

Letter to the Editor

Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma

Short report

Expression and distribution of PPP2R5C gene in leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits